¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãá°èÇмú´ëȸ : 2022-03-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãá°èÇмú´ëȸ : 2022-03-25
±³À°ÀÏÀÚ : 2022-03-25
±³À°Àå¼Ò : ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : 2022³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ
´ã´çÀÚ : À̼¼Àº
¿¬¶ôó : 02-784-2742  
À̸ÞÀÏ : secretariat@kcnp.or.kr      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ïºñ Æò»ýȸ¿ø:¸éÁ¦/Á¤È¸¿ø:50,000/ºñȸ¿ø:60,000/ÁØȸ¿ø¹×±âŸ:30,000 ´çÀϵî·Ïºñ Æò»ýȸ¿ø:10,000/Á¤È¸¿ø:60,000/ºñȸ¿ø:80,000/ÁØȸ¿ø¹×±âŸ:40,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 09:30~09:55 Suicide  ÀÌ»ó¹Î(°æÈñÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 09:55~10:20 Mood disorder  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 10:20~10:40 Addiction  ±èÀå·¡(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ09:30~09:55 Unipolar disorder vs bipolar disorder  ÀüÈ«ÁØ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ09:55~10:20 Schizophrenia vs personality disorder  ÀÌÁ¤¼®(±¹¹Î°Ç°­º¸ÇèÀϻ꺴¿ø) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ10:20~10:40 Organic mood disorder vs non-organic mood disorder  ÀÓÀº¼º(½Å¼¼°èÈ¿º´¿ø) 
È޽Ġ03-25  10:10~10:55   () 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 10:55~11:20 Immune system and depression  ½Å»óÈ£(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 11:20~11:45 Anti-inflammatory agents  ³ë´ë¿µ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 11:45~12:05 Repurposing drugs (ketamine, anti-diabetic, etc.)  ±è¼±¹Ì(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ10:55~11:20 Neurobiology of psychedelic drugs  ¿ÀÈ«¼®(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ11:20~11:45 MDMA and psychedelic-assisted psychotherapy  ³ªÀÇÇö(¿¹¼öº´¿ø) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ11:45~12:05 Psilocybin  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 12:05~12:35 A paradigm shift to recover from depression  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 12:35~13:05 Therapeutic advantage of Agomelatine in treating depression  ¼­Á¤¼®(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ12:05~12:35 Building best SPRAVATO clinical practice for TRD patients  Á¤¿µÀº(Á¦ÁÖÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ12:35~13:05 New community care model(CCM) with SPRAVATO  ¾çÂù¸ð(¿ø±¤ÀÇ´ë) 
È޽Ġ03-25  13:05~13:20   () 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 13:20~13:45 Manic/hypomanic and depressive episode  ¿ì¿µ¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 13:45~14:10 Mixed features and maintenance therapy  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 14:10~14:30 Rapid cycling and pharmacotherapy of special populations  Á¤Á¾Çö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ13:20~13:55 Emotional blunting and anhedonia management  Á¤¸íÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ13:55~14:30 Complexities in the management of elderly patients with MDD  ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 14:30~15:20 ¸ÞŸ¹ö½º¿¡ º´¿øÀ» ÁþÀÚ  ÃÖ¿ì½Ä(µö³ëÀ̵å) 
È޽Ġ03-25  15:20~15:30   () 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 15:30~15:55 Cholinesterase + Memantine for dementia  ÀÌÁØ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 15:55~16:20 Methylphenidate + Atomoxetine for adult ADHD  ¼ºÇü¸ð(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 03-25 ÄÁº¥¼ÇȦ 16:20~16:40 Long-acting injectable antipsychotics + AAP for schizophrenia  ¹Ú¼º¿ë(°è¿äº´¿ø) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ15:30~15:55 Current drug (AAP, Cariprazine, etc.)  È«Á¤¿Ï(Àͻ꺴¿ø) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ15:55~16:20 New drugs 1: Xanomeline-trospium, Ulotaront  Àå¿ÁÁø(±¹¸³ºÎ°îº´¿ø) 
±³À°½Ã°£ 03-25 ´ëȸÀǽǠ16:20~16:40 New drugs 2: Roluperidone, Pimavanserin  ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãá°èÇмú´ëȸ : 2022-03-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (3ÀÏÂ÷) : 2022-03-26
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¾È°ú ±Ý¿äÁý´ãȸ : 2022-03-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20988 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 1 16:11:23
20987 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 2 16:10:05
20986 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 2 16:08:54
20985 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 1 16:07:45
20984 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 0 16:06:35
20983 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 0 16:05:13
20982 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 1 16:04:00
20981 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 0 16:02:41
20980 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 0 16:01:31
20979 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 0 16:00:05
20978 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 0 15:58:38
20977 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 0 15:57:06
20976 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 0 15:55:34
20975 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 0 15:53:54
20974 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 0 15:52:18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷